166 related articles for article (PubMed ID: 33883615)
21. From ugly duckling to swan: unexpected identification from cell-SELEX of an anti-Annexin A2 aptamer targeting tumors.
Cibiel A; Quang NN; Gombert K; Thézé B; Garofalakis A; Ducongé F
PLoS One; 2014; 9(1):e87002. PubMed ID: 24489826
[TBL] [Abstract][Full Text] [Related]
22. Refining the Results of a Classical SELEX Experiment by Expanding the Sequence Data Set of an Aptamer Pool Selected for Protein A.
Stoltenburg R; Strehlitz B
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29495282
[TBL] [Abstract][Full Text] [Related]
23. In vitro selection of modified RNA aptamers against CD44 cancer stem cell marker.
Ababneh N; Alshaer W; Allozi O; Mahafzah A; El-Khateeb M; Hillaireau H; Noiray M; Fattal E; Ismail S
Nucleic Acid Ther; 2013 Dec; 23(6):401-7. PubMed ID: 24171482
[TBL] [Abstract][Full Text] [Related]
24. Selection of DNA aptamers for ovarian cancer biomarker HE4 using CE-SELEX and high-throughput sequencing.
Eaton RM; Shallcross JA; Mael LE; Mears KS; Minkoff L; Scoville DJ; Whelan RJ
Anal Bioanal Chem; 2015 Sep; 407(23):6965-73. PubMed ID: 25863801
[TBL] [Abstract][Full Text] [Related]
25. Characterisation of aptamer-target interactions by branched selection and high-throughput sequencing of SELEX pools.
Dupont DM; Larsen N; Jensen JK; Andreasen PA; Kjems J
Nucleic Acids Res; 2015 Dec; 43(21):e139. PubMed ID: 26163061
[TBL] [Abstract][Full Text] [Related]
26. Advancements in Aptamer Discovery Technologies.
Gotrik MR; Feagin TA; Csordas AT; Nakamoto MA; Soh HT
Acc Chem Res; 2016 Sep; 49(9):1903-10. PubMed ID: 27526193
[TBL] [Abstract][Full Text] [Related]
27. Selection of an aptamer against mouse GP2 by SELEX.
Hanazato M; Nakato G; Nishikawa F; Hase K; Nishikawa S; Ohno H
Cell Struct Funct; 2014; 39(1):23-9. PubMed ID: 24334484
[TBL] [Abstract][Full Text] [Related]
28. FSBC: fast string-based clustering for HT-SELEX data.
Kato S; Ono T; Minagawa H; Horii K; Shiratori I; Waga I; Ito K; Aoki T
BMC Bioinformatics; 2020 Jun; 21(1):263. PubMed ID: 32580745
[TBL] [Abstract][Full Text] [Related]
29. A truncated DNA aptamer with high selectivity for estrogen receptor-positive breast cancer cells.
Cong Y; Zhang SY; Li HM; Zhong JJ; Zhao W; Tang YJ
Int J Biol Macromol; 2023 Dec; 252():126450. PubMed ID: 37634779
[TBL] [Abstract][Full Text] [Related]
30. Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.
Kang D; Wang J; Zhang W; Song Y; Li X; Zou Y; Zhu M; Zhu Z; Chen F; Yang CJ
PLoS One; 2012; 7(10):e42731. PubMed ID: 23056171
[TBL] [Abstract][Full Text] [Related]
31. [DNA aptamers selection for breast cancer].
Zamay GS; Belayanina IV; Zamay AS; Komarova MA; Krat AV; Eremina EN; Zukov RA; Sokolov AE; Zamay TN
Biomed Khim; 2016 May; 62(4):411-7. PubMed ID: 27562994
[TBL] [Abstract][Full Text] [Related]
32. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
[TBL] [Abstract][Full Text] [Related]
33. Hi-Fi SELEX: A High-Fidelity Digital-PCR Based Therapeutic Aptamer Discovery Platform.
Ouellet E; Foley JH; Conway EM; Haynes C
Biotechnol Bioeng; 2015 Aug; 112(8):1506-22. PubMed ID: 25727321
[TBL] [Abstract][Full Text] [Related]
34. DNA aptamers against bacterial cells can be efficiently selected by a SELEX process using state-of-the art qPCR and ultra-deep sequencing.
Kolm C; Cervenka I; Aschl UJ; Baumann N; Jakwerth S; Krska R; Mach RL; Sommer R; DeRosa MC; Kirschner AKT; Farnleitner AH; Reischer GH
Sci Rep; 2020 Dec; 10(1):20917. PubMed ID: 33262379
[TBL] [Abstract][Full Text] [Related]
35. Recent developments in cell-SELEX technology for aptamer selection.
Kaur H
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2323-2329. PubMed ID: 30059712
[TBL] [Abstract][Full Text] [Related]
36. A cell-based single-stranded DNA aptamer specifically targets gastric cancer.
Zhang X; Zhang J; Ma Y; Pei X; Liu Q; Lu B; Jin L; Wang J; Liu J
Int J Biochem Cell Biol; 2014 Jan; 46():1-8. PubMed ID: 24501772
[TBL] [Abstract][Full Text] [Related]
37. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
[TBL] [Abstract][Full Text] [Related]
38. High-efficiency selection of aptamers for bovine lactoferrin by capillary electrophoresis and its aptasensor application in milk powder.
Zhu C; Li L; Yang G; Irfan M; Wang Z; Fang S; Qu F
Talanta; 2019 Dec; 205():120088. PubMed ID: 31450439
[TBL] [Abstract][Full Text] [Related]
39. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
[TBL] [Abstract][Full Text] [Related]
40. Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer.
Wan Q; Zeng Z; Qi J; Chen Z; Liu X; Zu Y
Mol Ther; 2022 Jun; 30(6):2242-2256. PubMed ID: 35143958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
